Home Your basket
• A rare and unusual cause ...
   Price 8.50 €
• Ectopic thyroid basi-ling...
   Price 10.50 €
• Failure rate and revision...
   Price 10.50 €
• Which face lift for which...
   Price 14.00 €
• Voice-breaking in adolesc...
   Price 10.50 €
• Osteoblastoma of the eth...
   Price 10.50 €
• Congenital bilateral choa...
   Price 5.50 €
• Management of labial inco...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Frontal sinus osteoma and...
   Price 5.50 €
• Multiple intracranial epi...
   Price 14.00 €
• Perceptual assessment of ...
   Price 10.50 €
• Thyroid surgery (356 case...
   Price 10.50 €
• A case of nasal NK/T cell...
   Price 5.50 €
• Modern lipostructure: The...
   Price 10.50 €
• Efficacy of voice therapy...
   Price 10.50 €
• Tinnitus: first symptom o...
   Price 5.50 €
• Sinonasal hemangiopericyt...
   Price 10.50 €
• The use of speech therapy...
   Price 10.50 €
• Quality of life before an...
   Price 10.50 €
• Effect of vestibular neur...
   Price 10.50 €
• Diagnosis and treatment o...
   Price 8.50 €
• Intranasal surgery: the r...
   Price 5.50 €
• Understanding the use of ...
   Price 10.50 €
• These lesions of the voca...
   Price 10.50 €
• Airbag and hearing loss: ...
   Price 8.50 €
• Acute infectious complica...
   Price 8.50 €
• New technique of myringop...
   Price 5.50 €
• Postural study on healthy...
   Price 10.50 €
• Retrosigmoid vestibular n...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Facial nerve monitoring d...
   Price 12.50 €
• Facial dissection applied...
   Price 14.00 €
• Side-to-end hypoglossal-f...
   Price 10.50 €

Total Order 319.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

HEAD AND NECK SURGERY

Utility of positron emission tomography for follow-up after therapy of head and neck squamous cell carcinomas


Authors : Cl. Conessa, Ph. Clement, H. Foehrenbach, Ph. Maszelin, P. Verdalle, M. Kossowski, J.-L. Poncet (Paris)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:253-258.

Article published in french
Downloadable PDF document french



Summary : This study aimed at pointing out the supply of the positron emission tomography (PET) in the posttherapeutic follow-up of the head and neck squamous cell carcinomas and to determine the best period to perform this test. Patients and methods: twenty patients have been included in this series, 16 men and 4 women. The PET was performed between 3 and 6 months after the end of all therapy. It systematically included radiation therapy. The results of the PET have been compared with those obtained by histology. The average distance of the follow-up of the patients after the achievement of the test was 11 months. Results: they divided up according to the presence or not of an abnormal fixation on the PET imaging. Negative PETs: eigth cases. Among those, a patient showed a metastatic cervical adenopathy at five months. Positive PETs: twelve cases which can be divided into three groups according to the area of the fixation. Primary site: 8 cases, 4 of which false-positive. Cervical lymph nodes: one case. Other sites: three cases. In our series PET had a sensitivity of 87% and a specificity of 67%. Conclusion: the PET is an original imaging as it allows a corporal metabolic study at one go. It seems to be very useful in the follow-up of patients who show a head and neck squamous cell carcinoma.The best period to perform it is the third or fourth posttherapeutic month. The high sensitivity is interesting within the context of an early detection of a residual tumour, for it allows to think of a suitable therapy quicker.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE